1. Home
  2. MYPS vs ESLA Comparison

MYPS vs ESLA Comparison

Compare MYPS & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PLAYSTUDIOS Inc.

MYPS

PLAYSTUDIOS Inc.

HOLD

Current Price

$0.46

Market Cap

60.2M

Sector

Technology

ML Signal

HOLD

Logo Estrella Immunopharma Inc.

ESLA

Estrella Immunopharma Inc.

HOLD

Current Price

$1.88

Market Cap

60.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYPS
ESLA
Founded
2011
2021
Country
United States
United States
Employees
543
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.2M
60.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MYPS
ESLA
Price
$0.46
$1.88
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$3.00
$8.00
AVG Volume (30 Days)
267.7K
162.3K
Earning Date
05-04-2026
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$0.78
52 Week High
$1.68
$3.15

Technical Indicators

Market Signals
Indicator
MYPS
ESLA
Relative Strength Index (RSI) 44.61 78.22
Support Level $0.42 $0.94
Resistance Level $0.53 $2.22
Average True Range (ATR) 0.04 0.19
MACD 0.00 0.10
Stochastic Oscillator 44.26 78.76

Price Performance

Historical Comparison
MYPS
ESLA

About MYPS PLAYSTUDIOS Inc.

PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Companies games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.

About ESLA Estrella Immunopharma Inc.

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.

Share on Social Networks: